{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:43:08Z","timestamp":1733877788884,"version":"3.30.1"},"reference-count":29,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1319-2442.174053","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T19:41:29Z","timestamp":1452886889000},"page":"15","source":"Crossref","is-referenced-by-count":5,"title":["The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism"],"prefix":"10.4103","volume":"27","author":[{"given":"Dilek","family":"Torun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Micozkadioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GulNihal","family":"Nursal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Yigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruya","family":"Ozelsancak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/1319-2442.174053-1","first-page":"S1","volume-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"Kidney","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/1319-2442.174053-2","first-page":"305","volume-title":"Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate","author":"Chertow","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-3","first-page":"1718","volume-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: The ACHIEVE study results","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-4","first-page":"2311","volume-title":"Combined therapy with cinacalcet and low doses of Vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.174053-5","first-page":"36","volume-title":"The OPTIMA study: Assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-6","first-page":"1186","volume-title":"Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: A three-year clinical experience","author":"Lucchi","year":"2011","journal-title":"Artif Organs"},{"key":"key-10.4103\/1319-2442.174053-7","first-page":"28","volume-title":"Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients","author":"Dr\u00fceke","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.174053-8","doi-asserted-by":"crossref","unstructured":"Mpio I, Boumendjel N, Karaaslan H, et al. Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study. Nephrol Ther 2011;7:229-36.","DOI":"10.1016\/j.nephro.2011.01.008"},{"key":"key-10.4103\/1319-2442.174053-9","first-page":"732","volume-title":"Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: Preliminary report","author":"Fusaro","year":"2011","journal-title":"Ren Fail"},{"key":"key-10.4103\/1319-2442.174053-10","first-page":"1","volume-title":"Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism","author":"Choi","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/1319-2442.174053-11","first-page":"450","volume-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1319-2442.174053-12","first-page":"1788","volume-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-13","first-page":"1179","volume-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.174053-14","first-page":"2208","volume-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-15","doi-asserted-by":"crossref","unstructured":"Henley C, Colloton M, Cattley RC, et al 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar\/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005;20:1370-7.","DOI":"10.1093\/ndt\/gfh834"},{"key":"key-10.4103\/1319-2442.174053-16","first-page":"2579","volume-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.174053-17","first-page":"982","volume-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.174053-18","first-page":"467","volume-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyper-parathyroidism","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.174053-19","first-page":"11","volume-title":"Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells","author":"Mizobuchi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/1319-2442.174053-20","first-page":"2482","volume-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","author":"EVOLVE","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-2442.174053-21","first-page":"e1001436","volume-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","author":"Palmer","year":"2013","journal-title":"PLoS Med"},{"key":"key-10.4103\/1319-2442.174053-22","first-page":"115","volume-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","author":"Str\u00f3zecki","year":"2001","journal-title":"Ren Fail"},{"key":"key-10.4103\/1319-2442.174053-23","first-page":"878","volume-title":"Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy","author":"Chow","year":"2003","journal-title":"J Nephrol"},{"key":"key-10.4103\/1319-2442.174053-24","first-page":"73","volume-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.174053-25","first-page":"229","volume-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1319-2442.174053-26","first-page":"1478","volume-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-2442.174053-27","first-page":"1014","volume-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","author":"Gu\u00e9rin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.174053-28","first-page":"245","volume-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.174053-29","first-page":"1815","volume-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","author":"Block","year":"2005","journal-title":"Kidney Int"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:51:07Z","timestamp":1498276267000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.sjkdt.org\/text.asp?2016\/27\/1\/15\/174053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["174053"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.174053","relation":{},"ISSN":["1319-2442"],"issn-type":[{"type":"print","value":"1319-2442"}],"subject":[],"published":{"date-parts":[[2016]]}}}